Clinical trials recruiting for Progressive Multiple Sclerosis
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Nicotinamid riboside | 1 |
| Obecabtagene autoleucel (obe-cel) | 1 |
| Ocrelizumab | 1 |
| RO7268489 | 1 |
| rapcabtagene autoleucel (YTB323) | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Michigan | 1 |
Top cities
Self-screener
Recruiting trials
- A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)
- Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) Patients
- Effects of Transcranial Static Magnetic Field Stimulation (tSMS) in Progressive Multiple Sclerosis
- Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis
- Obe-cel in Refractory Progressive Forms of Multiple Sclerosis
- Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS)
Related conditions
Trials recruiting for Progressive Multiple Sclerosis often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Progressive Multiple Sclerosis trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.